Broadridge Names Laura Matlin as Chief Governance Officer

Tuesday, 17/11/2015 | 10:04 GMT by Jeff Patterson
  • Laura Matlin moves to the newly created role of Chief Governance Officer with Julie Taylor joining as the Chief Human Resources Officer.
Broadridge Names Laura Matlin as Chief Governance Officer
Bloomberg

Broadridge Financial Solutions, Inc. (NYSE:BR) has appointed Julie Taylor as the newest member of its executive committee and Chief Human Resources Officer (CHRO), according to a Broadridge statement.

Ms. Taylor will be succeeding Laura Matlin, who has served as Broadridge’s CHRO since last year. Per the new appointment, Ms. Matlin will resume her prior legal duties as the group’s deputy general counsel as well as assuming the newly-created role of Chief Governance Officer – she will remain on the group’s executive committee.

In her new role, Ms. Taylor will be reporting to Richard J. Daly, Broadridge’s President and Chief Executive Officer (CEO), where she will help manage all of the company’s human resources capabilities and functions.

Taylor has worked most recently in a similar level role at Pall Corporation, along with a stint as the Vice President of Human Resources for U.S. pharmaceuticals at Bristol-Myers Squibb.

“The addition of Julie to our team underscores our commitment to recruiting talented professionals, who will enhance our standing as both a leader and an employer of choice in our industry. I am grateful for the extraordinary leadership and critical business judgment Laura has demonstrated as acting CHRO, and I look forward to her growing contributions and leadership in the newly-formed role of chief governance officer,” noted Mr. Daly in a statement on the appointment.

Last week, Broadridge acquired QED Financial Systems, Inc., a privately held investment accounting solutions provider for an undisclosed sum. QED provides a number of solutions and serves across such channels as data management and outsourced investment accounting – the group primarily caters to institutional investors and asset managers who collectively comprise a total of $1.5 trillion in assets under management.

Broadridge Financial Solutions, Inc. (NYSE:BR) has appointed Julie Taylor as the newest member of its executive committee and Chief Human Resources Officer (CHRO), according to a Broadridge statement.

Ms. Taylor will be succeeding Laura Matlin, who has served as Broadridge’s CHRO since last year. Per the new appointment, Ms. Matlin will resume her prior legal duties as the group’s deputy general counsel as well as assuming the newly-created role of Chief Governance Officer – she will remain on the group’s executive committee.

In her new role, Ms. Taylor will be reporting to Richard J. Daly, Broadridge’s President and Chief Executive Officer (CEO), where she will help manage all of the company’s human resources capabilities and functions.

Taylor has worked most recently in a similar level role at Pall Corporation, along with a stint as the Vice President of Human Resources for U.S. pharmaceuticals at Bristol-Myers Squibb.

“The addition of Julie to our team underscores our commitment to recruiting talented professionals, who will enhance our standing as both a leader and an employer of choice in our industry. I am grateful for the extraordinary leadership and critical business judgment Laura has demonstrated as acting CHRO, and I look forward to her growing contributions and leadership in the newly-formed role of chief governance officer,” noted Mr. Daly in a statement on the appointment.

Last week, Broadridge acquired QED Financial Systems, Inc., a privately held investment accounting solutions provider for an undisclosed sum. QED provides a number of solutions and serves across such channels as data management and outsourced investment accounting – the group primarily caters to institutional investors and asset managers who collectively comprise a total of $1.5 trillion in assets under management.

About the Author: Jeff Patterson
Jeff Patterson
  • 5448 Articles
  • 113 Followers
Head of Commercial Content

More from the Author

Executives